Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	76.5	87.93	169.68	14.6	21.3	49.22
Short-Term Investments	210.34	203.51	-	-	-	-
Cash & Short-Term Investments	286.84	291.44	169.68	14.6	21.3	49.22
Cash Growth	7.79%	71.76%	1062.04%	-31.46%	-56.72%	137.42%
Receivables	24.62	-	-	-	-	-
Inventory	2.36	-	-	-	-	-
Prepaid Expenses	2.97	2.45	1.68	1.05	1.12	1.02
Total Current Assets	316.79	293.89	171.36	15.65	22.42	50.24
Property, Plant & Equipment	2.6	2.98	0.42	0.16	0.45	0.16
Long-Term Investments	7	27.21	-	-	-	-
Other Intangible Assets	5.83	6.81	8.75	10.69	12.64	14.58
Other Long-Term Assets	0.08	0.08	0.17	-	0.04	-
Total Assets	332.31	330.97	180.69	26.5	35.55	64.98
Accounts Payable	6.22	8.88	3.15	1.78	3.25	3.49
Accrued Expenses	8.54	6.6	6.53	4.9	4.15	4.79
Current Portion of Leases	0.68	0.53	0.27	0.16	0.28	0.15
Other Current Liabilities	5.51	2.74	1.56	0.48	0.32	0.19
Total Current Liabilities	20.94	18.75	11.51	7.31	8.01	8.62
Long-Term Debt	49.85	49.83	-	-	-	-
Long-Term Leases	2.25	2.47	0.13	-	0.18	-
Other Long-Term Liabilities	19.13	14.81	11.55	8.84	9.58	10.82
Total Liabilities	92.17	85.86	23.18	16.15	17.76	19.44
Common Stock	0.05	0.05	0.03	0.01	0.08	0.08
Additional Paid-In Capital	740.75	696.97	433.89	247.76	231.07	227.91
Retained Earnings	-500.74	-452.26	-276.41	-237.42	-213.36	-182.45
Comprehensive Income & Other	0.09	0.36	-	-	-	-
Total Common Equity	240.14	245.11	157.51	10.35	17.79	45.55
Shareholders' Equity	240.14	245.11	157.51	10.35	17.79	45.55
Total Liabilities & Equity	332.31	330.97	180.69	26.5	35.55	64.98
Total Debt	52.77	52.83	0.4	0.16	0.46	0.15
Net Cash (Debt)	241.07	265.82	169.28	14.45	20.85	49.08
Net Cash Growth	-18.09%	57.03%	1071.72%	-30.70%	-57.52%	142.19%
Net Cash Per Share	5.28	6.62	10.26	1.72	3.92	11.76
Filing Date Shares Outstanding	53.15	45.86	32.46	8.17	5.34	5.31
Total Common Shares Outstanding	50.44	45.7	31.68	8.16	5.32	5.31
Working Capital	295.85	275.14	159.85	8.33	14.42	41.63
Book Value Per Share	4.76	5.36	4.97	1.27	3.34	8.58
Tangible Book Value	234.31	238.31	148.76	-0.35	5.16	30.97
Tangible Book Value Per Share	4.65	5.21	4.70	-0.04	0.97	5.83
Machinery	-	0.2	0.1	0.1	0.1	0.05
Leasehold Improvements	-	0.05	-	-	-	-

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q